Analysis

  • Using AI to personalise drug combination therapy

    Doctors routinely employ a combination therapy strategy for cancer patients, but figuring out which drugs to use is a challenge. Researchers at the National University of Singapore have developed an...

  • October’s top news stories

    The US President outlined a new payment model to lower drug prices in the country, and Novartis signed a $2.1bn deal to purchase all outstanding shares of Endocyte. Pharmaceutical-technology.com wraps...